Announcements Trials
Browse Landscape

Phase

Phase 4 2

Status

Recruiting 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Conditions

Pain 11Neoplasms 5Cancer Pain 4Pain, Postoperative 2Malignant Female Reproductive System Neoplasm 2Hematologic Neoplasms 2Emergencies 2Agnosia 2Uterine Cervical Neoplasms 1Tumor Surgery 1Sarcoma 1Rectal Neoplasms 1Pulmonary Nodule 1Prostatic Neoplasms 1Postoperative Complications 1Pancreatic Neoplasms 1Pain, Intractable 1Ovarian Neoplasms 1Neuralgia 1Neoplasm Metastasis 1Mucositis 1Lymphoma, Follicular 1Liver Neoplasms 1Leukemia 1Kidney Neoplasms 1Intraoperative Complications 1Ileus 1Fallopian Tube Neoplasms 1Endometrial Neoplasms 1Duodenal Neoplasms 1

Interventions

Specimen Handling 2Palliative Care 2Interviews as Topic 2Hydromorphone 2palbociclib 1neratinib 1Therapeutics 1Rehabilitation 1Referral and Consultation 1Organizational Objectives 1Methods 1Methadone 1Mental Status and Dementia Tests 1Magnetic Resonance Spectroscopy 1Laparotomy 1Heparin 1Enoxaparin 1Educational Status 1Early Intervention, Educational 1Biopsy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Malignant Female Reproductive System Neoplasm × Hydromorphone × Clear all
NCT06525740 2026-03-04

Methadone Versus Intrathecal Hydromorphone for Postoperative Pain Relief in Gynecologic Cancer Undergoing Surgery

Mayo Clinic

Phase 4 Recruiting
140 enrolled

Malignant Female Reproductive System Neoplasm

NCT04258631 2024-10-16

Liposomal Bupivacaine With or Without Hydromorphone for the Improvement of Pain Control After Laparotomy in Patients With Gynecological Malignancies

Mayo Clinic

Phase 4 Completed
105 enrolled 22 charts

Malignant Female Reproductive System Neoplasm

Data powered by HemOnc (CC BY 4.0) Colophon âš¡